Critical Changes to Co-Pay Assistance Programs in 2021: What Biopharmaceutical Manufacturers Need to Know

Provided By:

TrialCard Incorporated

October 29, 2020

As the market landscape relative to co-pay assistance programs continues to evolve, it is important for biopharmaceutical manufacturers to have a practical strategy in place.  This white paper provides valuable insight into planning for 2021 and beyond.

TrialCard Incorporated provides patient affordability, medication access and adherence, patient support, and clinical trial services on behalf of biopharmaceutical manufacturers. Founded in 2000, TrialCard has connected over 33 million patients with nearly $15 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina. For more information about TrialCard, please view this video.

Posted in: Access, Commercial, Pricing

Post a Comment

You must be logged in to post a Comment.

FEEDBACK